Labeling Type
VACCINE LABEL
Status
Approved
Full Title
These highlights do not include all the information needed to use COMIRNATY safely and effectively. See full prescribing information for COMIRNATY. COMIRNATY(COVID-19 Vaccine, mRNA) injectable suspension, for intramuscular use2026-2027 FormulaInitial U.S. Approval: 2021
United States
Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.
